Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endoscopic Mucosal Resection | 17 | 2025 | 81 | 4.120 |
Why?
|
| Myotomy | 6 | 2025 | 22 | 1.820 |
Why?
|
| Capsule Endoscopy | 5 | 2021 | 20 | 1.680 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2021 | 225 | 1.330 |
Why?
|
| Esophageal Achalasia | 3 | 2025 | 48 | 1.300 |
Why?
|
| Natural Orifice Endoscopic Surgery | 5 | 2025 | 81 | 1.290 |
Why?
|
| Colonic Polyps | 4 | 2025 | 86 | 1.180 |
Why?
|
| Esophagoscopy | 4 | 2025 | 175 | 1.160 |
Why?
|
| Esophageal Neoplasms | 6 | 2024 | 392 | 1.010 |
Why?
|
| Esophageal Sphincter, Lower | 2 | 2025 | 16 | 0.990 |
Why?
|
| Traction | 1 | 2025 | 10 | 0.950 |
Why?
|
| Endoscopy, Gastrointestinal | 3 | 2024 | 233 | 0.930 |
Why?
|
| Colonoscopy | 6 | 2025 | 247 | 0.920 |
Why?
|
| Wound Closure Techniques | 1 | 2025 | 29 | 0.900 |
Why?
|
| Suture Techniques | 1 | 2025 | 180 | 0.830 |
Why?
|
| Colorectal Neoplasms | 6 | 2025 | 639 | 0.780 |
Why?
|
| Pancreas | 2 | 2025 | 218 | 0.780 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 322 | 0.760 |
Why?
|
| Colon | 2 | 2022 | 361 | 0.720 |
Why?
|
| Operative Time | 5 | 2025 | 205 | 0.710 |
Why?
|
| Feasibility Studies | 1 | 2024 | 838 | 0.680 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 68 | 0.650 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2025 | 38 | 0.650 |
Why?
|
| Pancreatic Cyst | 1 | 2019 | 28 | 0.600 |
Why?
|
| Hematemesis | 1 | 2018 | 5 | 0.580 |
Why?
|
| Treatment Outcome | 20 | 2025 | 12997 | 0.570 |
Why?
|
| Endoscopy, Digestive System | 2 | 2018 | 154 | 0.560 |
Why?
|
| Pancreatitis | 1 | 2019 | 140 | 0.550 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 329 | 0.540 |
Why?
|
| Aged | 22 | 2025 | 21263 | 0.530 |
Why?
|
| Pancreatic Neoplasms | 2 | 2024 | 732 | 0.530 |
Why?
|
| Delayed Diagnosis | 1 | 2018 | 131 | 0.510 |
Why?
|
| Neoplasm, Residual | 4 | 2025 | 136 | 0.510 |
Why?
|
| Middle Aged | 22 | 2025 | 28897 | 0.440 |
Why?
|
| Esophageal Motility Disorders | 2 | 2025 | 21 | 0.440 |
Why?
|
| Prospective Studies | 10 | 2025 | 6509 | 0.430 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 759 | 0.400 |
Why?
|
| Humans | 40 | 2025 | 131781 | 0.390 |
Why?
|
| Endosonography | 2 | 2025 | 79 | 0.370 |
Why?
|
| Male | 26 | 2025 | 65290 | 0.360 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 999 | 0.340 |
Why?
|
| Cost-Benefit Analysis | 2 | 2025 | 544 | 0.330 |
Why?
|
| Gastroenterology | 2 | 2024 | 220 | 0.310 |
Why?
|
| Aged, 80 and over | 8 | 2025 | 6916 | 0.300 |
Why?
|
| Female | 23 | 2025 | 71221 | 0.290 |
Why?
|
| Surgical Instruments | 2 | 2025 | 56 | 0.280 |
Why?
|
| Learning Curve | 2 | 2025 | 58 | 0.270 |
Why?
|
| Gastrointestinal Tract | 2 | 2021 | 225 | 0.270 |
Why?
|
| Retrospective Studies | 17 | 2025 | 17667 | 0.260 |
Why?
|
| Barrett Esophagus | 2 | 2021 | 358 | 0.260 |
Why?
|
| Gastrointestinal Neoplasms | 3 | 2024 | 85 | 0.260 |
Why?
|
| Propensity Score | 2 | 2025 | 265 | 0.240 |
Why?
|
| Duodenoscopy | 1 | 2025 | 17 | 0.230 |
Why?
|
| Pancreatic Diseases | 1 | 2025 | 42 | 0.230 |
Why?
|
| Duodenal Neoplasms | 1 | 2025 | 28 | 0.230 |
Why?
|
| Neuroendocrine Tumors | 1 | 2025 | 59 | 0.220 |
Why?
|
| Gastroenterologists | 1 | 2024 | 14 | 0.220 |
Why?
|
| Intestinal Polyps | 1 | 2024 | 30 | 0.220 |
Why?
|
| Electrosurgery | 1 | 2024 | 17 | 0.210 |
Why?
|
| Standard of Care | 3 | 2019 | 135 | 0.210 |
Why?
|
| Gels | 1 | 2024 | 70 | 0.210 |
Why?
|
| Esophageal Stenosis | 1 | 2024 | 46 | 0.210 |
Why?
|
| Adenoma | 1 | 2025 | 146 | 0.210 |
Why?
|
| Salvage Therapy | 1 | 2025 | 178 | 0.200 |
Why?
|
| Fundoplication | 1 | 2024 | 70 | 0.200 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 251 | 0.200 |
Why?
|
| Oncolytic Viruses | 1 | 2024 | 75 | 0.200 |
Why?
|
| Aftercare | 1 | 2024 | 154 | 0.200 |
Why?
|
| Mentoring | 1 | 2024 | 80 | 0.190 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2023 | 87 | 0.190 |
Why?
|
| Adipose Tissue | 1 | 2025 | 495 | 0.190 |
Why?
|
| Equipment Design | 1 | 2024 | 555 | 0.190 |
Why?
|
| Anemia | 2 | 2024 | 356 | 0.180 |
Why?
|
| Postoperative Care | 1 | 2024 | 303 | 0.180 |
Why?
|
| Thrombocytopenia | 1 | 2024 | 222 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2025 | 265 | 0.180 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 333 | 0.170 |
Why?
|
| Cytodiagnosis | 1 | 2020 | 20 | 0.160 |
Why?
|
| Bile Ducts | 1 | 2020 | 53 | 0.160 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 75 | 0.160 |
Why?
|
| Equivalence Trials as Topic | 1 | 2019 | 22 | 0.160 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2019 | 30 | 0.150 |
Why?
|
| Adult | 8 | 2025 | 31710 | 0.150 |
Why?
|
| Costs and Cost Analysis | 1 | 2019 | 155 | 0.150 |
Why?
|
| Intestine, Small | 1 | 2021 | 287 | 0.150 |
Why?
|
| Bile Duct Neoplasms | 1 | 2020 | 131 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 1 | 2025 | 1304 | 0.140 |
Why?
|
| Unnecessary Procedures | 1 | 2018 | 63 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2019 | 199 | 0.140 |
Why?
|
| Postoperative Complications | 3 | 2025 | 3134 | 0.130 |
Why?
|
| Inulin | 1 | 2016 | 17 | 0.130 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 267 | 0.130 |
Why?
|
| Fatty Acids, Volatile | 1 | 2016 | 45 | 0.120 |
Why?
|
| Acute Disease | 1 | 2019 | 1153 | 0.120 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2025 | 1280 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 900 | 0.110 |
Why?
|
| Quality of Life | 1 | 2024 | 2115 | 0.100 |
Why?
|
| Length of Stay | 1 | 2019 | 1400 | 0.100 |
Why?
|
| Obesity | 1 | 2025 | 2390 | 0.100 |
Why?
|
| United States | 4 | 2025 | 11815 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 891 | 0.090 |
Why?
|
| Time Factors | 2 | 2018 | 6279 | 0.090 |
Why?
|
| Risk Factors | 2 | 2024 | 10965 | 0.070 |
Why?
|
| Young Adult | 2 | 2020 | 10102 | 0.070 |
Why?
|
| Intestinal Mucosa | 2 | 2023 | 765 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3917 | 0.070 |
Why?
|
| Esophageal Spasm, Diffuse | 1 | 2025 | 3 | 0.060 |
Why?
|
| Duodenum | 1 | 2025 | 112 | 0.050 |
Why?
|
| Margins of Excision | 1 | 2024 | 56 | 0.050 |
Why?
|
| Albumins | 1 | 2024 | 92 | 0.050 |
Why?
|
| North America | 1 | 2024 | 257 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2024 | 134 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2024 | 262 | 0.050 |
Why?
|
| Rectum | 1 | 2023 | 103 | 0.050 |
Why?
|
| Bayes Theorem | 1 | 2024 | 306 | 0.050 |
Why?
|
| Sutures | 1 | 2022 | 65 | 0.050 |
Why?
|
| Brazil | 1 | 2022 | 140 | 0.040 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 278 | 0.040 |
Why?
|
| Gastric Mucosa | 1 | 2024 | 491 | 0.040 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2020 | 23 | 0.040 |
Why?
|
| Opioid-Related Disorders | 1 | 2024 | 293 | 0.040 |
Why?
|
| Peptides | 1 | 2024 | 835 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 327 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2021 | 335 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 498 | 0.040 |
Why?
|
| Professional Practice | 1 | 2019 | 41 | 0.040 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2020 | 75 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 228 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2024 | 1457 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2024 | 698 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2024 | 726 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2024 | 471 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2020 | 126 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2025 | 1695 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2019 | 282 | 0.040 |
Why?
|
| Melena | 1 | 2018 | 5 | 0.040 |
Why?
|
| Stomach Neoplasms | 1 | 2024 | 579 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2018 | 192 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 1252 | 0.030 |
Why?
|
| Propionates | 1 | 2016 | 34 | 0.030 |
Why?
|
| Esters | 1 | 2016 | 33 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2024 | 1356 | 0.030 |
Why?
|
| Fermentation | 1 | 2016 | 67 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2993 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 562 | 0.030 |
Why?
|
| Hospitalization | 1 | 2025 | 1942 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 332 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2148 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 1406 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 1405 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 4053 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 382 | 0.030 |
Why?
|
| Energy Intake | 1 | 2016 | 501 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1838 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2020 | 1051 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2022 | 5122 | 0.020 |
Why?
|
| Feces | 1 | 2016 | 725 | 0.020 |
Why?
|
| Adolescent | 1 | 2020 | 20994 | 0.010 |
Why?
|
| Child | 1 | 2020 | 26316 | 0.010 |
Why?
|